Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine + Corticosteroids in Severe Acute Alcoholic Hepatitis
NCT05294744Completed
- Sponsor
- Bioaraba Health Research Institute
- Start
- Oct 2022
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine in alcoholic hepatitis (AH) (2 arms), sponsored by Bioaraba Health Research Institute. Primary endpoint: All-cause mortality at 6 months. Started Oct 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT05294744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294744.